Intensity Therapeutics In...

NASDAQ: INTS · Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM

Intensity Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-16.27M -10.54M -7.58M -7.9M
Depreciation & Amortization
n/a n/a 179.04K n/a
Stock-Based Compensation
3.07M 1.4M 1.17M 719.82K
Other Working Capital
167K -2.26M 326.02K 227K
Other Non-Cash Items
76K 2.57M 179.04K 172.11K
Deferred Income Tax
n/a n/a -179.04K n/a
Change in Working Capital
-2.1M -633K 756.69K 176.8K
Operating Cash Flow
-15.22M -7.21M -5.48M -6.83M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-3.06M -15.05M n/a n/a
Sales Maturities Of Investments
n/a 9.03M n/a n/a
Other Investing Acitivies
9.41M n/a n/a n/a
Investing Cash Flow
6.35M -6.02M n/a n/a
Debt Repayment
n/a 230K 2.25M 2M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-332K -2.18M n/a 50K
Financial Cash Flow
2.9M 20.47M 2.25M 2.05M
Net Cash Flow
-5.97M 7.24M -3.23M -4.78M
Free Cash Flow
-15.22M -7.21M -5.48M -6.83M